ATE455086T1 - Verfahren zur stabilisierung von reduziertem coenzym q10 und verfahren zur sauren kristallisation - Google Patents

Verfahren zur stabilisierung von reduziertem coenzym q10 und verfahren zur sauren kristallisation

Info

Publication number: ATE455086T1
Authority: AT; Austria
Prior art keywords: reduced coenzyme; acid; crystalization; stabilizing reduced; stabilizing
Prior art date: 2001-07-16

Application number

AT02746041T

Other languages

English (en)

Inventor

Takahiro Ueda

Shiro Kitamura

Yasuyoshi Ueda

Original Assignee

Kaneka Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-16

Filing date

2002-07-15

Publication date

2010-01-15

2002-07-15 Application filed by Kaneka Corp filed Critical Kaneka Corp

2010-01-15 Application granted granted Critical

2010-01-15 Publication of ATE455086T1 publication Critical patent/ATE455086T1/de

Links

QNTNKSLOFHEFPK-UPTCCGCDSA-N ubiquinol-10 Chemical compound COC1=C(O)C(C)=C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=C1OC QNTNKSLOFHEFPK-UPTCCGCDSA-N 0.000 title abstract 4
239000002253 acid Substances 0.000 title abstract 3
230000000087 stabilizing effect Effects 0.000 title abstract 2
239000000463 material Substances 0.000 abstract 2
MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 abstract 1
229910001882 dioxygen Inorganic materials 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000010534 mechanism of action Effects 0.000 abstract 1
230000003647 oxidation Effects 0.000 abstract 1
238000007254 oxidation reaction Methods 0.000 abstract 1
239000002904 solvent Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
- C07C41/01—Preparation of ethers
- C07C41/18—Preparation of ethers by reactions not forming ether-oxygen bonds
- C07C41/26—Preparation of ethers by reactions not forming ether-oxygen bonds by introduction of hydroxy or O-metal groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
- C07C41/01—Preparation of ethers
- C07C41/34—Separation; Purification; Stabilisation; Use of additives
- C07C41/40—Separation; Purification; Stabilisation; Use of additives by change of physical state, e.g. by crystallisation
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
- C07C41/01—Preparation of ethers
- C07C41/34—Separation; Purification; Stabilisation; Use of additives
- C07C41/46—Use of additives, e.g. for stabilisation

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Crystallography & Structural Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Saccharide Compounds (AREA)

AT02746041T 2001-07-16 2002-07-15 Verfahren zur stabilisierung von reduziertem coenzym q10 und verfahren zur sauren kristallisation ATE455086T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2001215804		2001-07-16
JP2002114878		2002-04-17
PCT/JP2002/007148 WO2003008363A1 (fr)	2001-07-16	2002-07-15	Procede de stabilisation d'une coenzyme q10 reduite et technique de cristallisation en presence d'acide

Publications (1)

Publication Number	Publication Date
ATE455086T1 true ATE455086T1 (de)	2010-01-15

Family

ID=26618815

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02746041T ATE455086T1 (de)	2001-07-16	2002-07-15	Verfahren zur stabilisierung von reduziertem coenzym q10 und verfahren zur sauren kristallisation

Country Status (11)

Country	Link
US (1)	US7169590B2 (de)
EP (1)	EP1415973B1 (de)
JP (1)	JP4149917B2 (de)
KR (1)	KR20040018464A (de)
CN (1)	CN1254462C (de)
AT (1)	ATE455086T1 (de)
AU (1)	AU2002318516B2 (de)
CA (1)	CA2453135A1 (de)
DE (1)	DE60235089D1 (de)
TW (1)	TWI235146B (de)
WO (1)	WO2003008363A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI349039B (en) *	2001-12-27	2011-09-21	Kaneka Corp	Processes for producing coenzyme q10
TW200302056A (en) *	2002-01-18	2003-08-01	Kaneka Corp	Method for stabilizing reduced coenzyme Q10 and composition therefor
US7358402B2 (en) *	2003-09-10	2008-04-15	Kaneka Corporation	Reduced coenzyme Q10 crystal with excellent stability and composition containing said reduced coenzyme Q10 crystal
ES2410587T3 (es)	2004-01-22	2013-07-02	University Of Miami	Formulaciones tópicas de coenzima Q10 y métodos de uso
US20060147542A1 (en) *	2004-12-24	2006-07-06	Tadao Ono	Solid preparation containing reduced coenzyme Q10 and method for producing the same
US8067217B2 (en) *	2004-12-28	2011-11-29	Kaneka Corporation	Method for preserving reduced coenzyme Q10
EP2025662A4 (de) *	2006-04-28	2011-07-27	Kaneka Corp	Verfahren zur aufreinigung von reduziertem coenzym q10
MX337408B (es)	2007-03-22	2016-03-03	Berg Llc	Formulaciones topicas que tienen biodisponibilidad aumentada.
WO2009126764A1 (en)	2008-04-11	2009-10-15	Cytotech Labs, Llc	Methods and use of inducing apoptosis in cancer cells
CN101307338B (zh) *	2008-07-17	2012-04-25	任雷	还原型辅酶q10的制备方法
EA023913B1 (ru) *	2009-05-11	2016-07-29	БЕРГ ФАРМА ЭлЭлСи	Способы лечения метаболических нарушений, использующие эпиметаболические переключатели, многоаспектные внутриклеточные молекулы или факторы влияния
KR101907411B1 (ko)	2010-03-12	2018-10-12	베르그 엘엘씨	코엔자임 Ｑ10(ＣｏＱ10)의 정맥내 제형 및 이의 사용 방법
KR101038916B1 (ko) *	2011-03-17	2011-06-07	노새미	콘크리트 저수조의 짜임공법식 내벽 마감구조
CN103608323B (zh)	2011-04-04	2016-08-17	博格有限责任公司	治疗中枢神经系统肿瘤的方法
CN107095863A (zh)	2011-06-17	2017-08-29	博格有限责任公司	可吸入药物组合物
CA2837695C (en) *	2011-06-24	2019-12-31	Kaneka Corporation	Reduced coenzyme q10 crystal having excellent stability
EP2983654B1 (de)	2013-04-08	2025-11-12	BPGbio, Inc.	Behandlung von krebs mit coenzym-q10-kombinationstherapien
WO2015035094A1 (en)	2013-09-04	2015-03-12	Berg Llc	Methods of treatment of cancer by continuous infusion of coenzyme q10
US20170189350A1 (en)	2015-11-16	2017-07-06	Berg Llc	Methods of treatment of temozolomide-resistant glioma using coenzyme q10
CN105833793B (zh) *	2015-12-21	2019-04-02	神舟生物科技有限责任公司	一种工业生产辅酶q10的工艺方法
JP7389044B2 (ja) *	2018-09-28	2023-11-29	株式会社カネカ	安定性に優れた還元型補酵素ｑ１０結晶の製造方法
CN113024362B (zh) *	2021-03-10	2022-02-15	中国科学院上海药物研究所	一种辅酶qh与烟酰胺的共晶及其制备方法和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL6712642A (de) *	1966-09-17	1968-03-18
JPS5915894B2 (ja)	1975-12-15	1984-04-12	ニツシンセイフンカブシキガイシヤ	ホコウソｑノセイゾウホウホウ
JPS609796B2 (ja)	1977-04-21	1985-03-13	日清製粉株式会社	補酵素ｑの製造法
JPS56140947A (en) *	1980-04-03	1981-11-04	Sekisui Chem Co Ltd	Production of coenzyme q
AU4510596A (en) *	1994-12-06	1996-06-26	National Research Council Of Canada	Water soluble ubiquinone compositions, prodrugs, and methods relating thereto
JP3889481B2 (ja)	1996-08-16	2007-03-07	株式会社カネカ	医薬組成物
US8753675B1 (en)	2000-01-20	2014-06-17	Raj K. Chopra	Reduced form of Coenzyme Q in high bioavailability stable dosage forms and related applications

2002
- 2002-07-12 TW TW091115494A patent/TWI235146B/zh not_active IP Right Cessation
- 2002-07-15 JP JP2003513924A patent/JP4149917B2/ja not_active Expired - Fee Related
- 2002-07-15 EP EP02746041A patent/EP1415973B1/de not_active Expired - Lifetime
- 2002-07-15 CN CNB028137051A patent/CN1254462C/zh not_active Expired - Lifetime
- 2002-07-15 KR KR10-2004-7000608A patent/KR20040018464A/ko not_active Ceased
- 2002-07-15 AT AT02746041T patent/ATE455086T1/de not_active IP Right Cessation
- 2002-07-15 AU AU2002318516A patent/AU2002318516B2/en not_active Ceased
- 2002-07-15 CA CA002453135A patent/CA2453135A1/en not_active Abandoned
- 2002-07-15 WO PCT/JP2002/007148 patent/WO2003008363A1/ja not_active Ceased
- 2002-07-15 DE DE60235089T patent/DE60235089D1/de not_active Expired - Lifetime
- 2002-07-15 US US10/484,227 patent/US7169590B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP1415973B1 (de)	2010-01-13
US20040197418A1 (en)	2004-10-07
CA2453135A1 (en)	2003-01-30
CN1254462C (zh)	2006-05-03
AU2002318516B2 (en)	2007-12-06
EP1415973A4 (de)	2006-02-01
KR20040018464A (ko)	2004-03-03
WO2003008363A1 (fr)	2003-01-30
AU2002318516A2 (en)	2003-03-03
TWI235146B (en)	2005-07-01
JP4149917B2 (ja)	2008-09-17
DE60235089D1 (de)	2010-03-04
JPWO2003008363A1 (ja)	2004-11-04
EP1415973A1 (de)	2004-05-06
US7169590B2 (en)	2007-01-30
CN1525951A (zh)	2004-09-01

Similar Documents

Publication	Publication Date	Title
DE60235089D1 (de)	2010-03-04	Verfahren zur stabilisierung von reduziertem coenzym q10 und verfahren zur sauren kristallisation
ATE511508T1 (de)	2011-06-15	Verfahren zur kristallisation von (r)- oder (s)- lansoprazol
EE05485B1 (et)	2011-10-17	Plasmi(i)n(ogeen)i eemaldamine valgulahustest
DE50005699D1 (de)	2004-04-22	Verfahren zur herstellung von thiazolidin
DE69931753D1 (de)	2006-07-20	Azoverbindungen sowie verfahren zur herstellung derselben
ATE554178T1 (de)	2012-05-15	Verfahren zur herstellung von aminosäurederivaten aus hydroxyiminosäuren
DE502005006938D1 (de)	2009-05-07	Verfahren zur Herstellung von aliphatischen geradkettigen und ß-alkylverzweigten Carbonsäuren
DE60233664D1 (de)	2009-10-22	Verfahren zur herstellung von pyridinverbindungen
ATE324360T1 (de)	2006-05-15	Oxidationsverfahren zur herstellung von alkenen und carbonsäuren
DE60207490D1 (de)	2005-12-29	Verfahren zur Herstellung von (Meth)Acrylsäureanhydrid
DE69231815D1 (de)	2001-06-13	Verfahren zur Herstellung von Cephalosporinen und Zwischenprodukte in diesem Verfahren
DE69205842D1 (de)	1995-12-07	Verfahren zur herstellung von flunixin und zwischenprodukten dafür.
ATE271533T1 (de)	2004-08-15	Verfahren zur herstellung von alkincarbonsäuren durch oxidation von alkinalkoholen
ATE446308T1 (de)	2009-11-15	Verfahren zur herstellung von cinnamylaldehyd- derivaten und ihre verwendung
DE60100217D1 (de)	2003-06-05	Verfahren zur Herstellung von hochkonzentrierten Kohlendioxid
DE69523038D1 (de)	2001-11-08	Verfahren zur herstellung von hiv proteasinhibitoren
ATE215968T1 (de)	2002-04-15	Verfahren zur reinigung von thrombomodulin
DE60200535D1 (de)	2004-07-01	Verfahren zur Herstellung von hoch reinem Pemirolast
ATE529392T1 (de)	2011-11-15	Verfahren zur oxidation von kohlenwasserstoffen in carbonsäuren
DE60040592D1 (de)	2008-12-04	Verfahren zur herstellung von alpha-aminoketonen
DE602004018417D1 (de)	2009-01-29	Verfahren zur Herstellung von Sulfinyl- oder Sulfonyl- Verbindungen in Gegenwart von epsilon-Phthalimidoperhexansäure
DE69925836D1 (de)	2005-07-21	Ein verfahren zur herstellung von 4-carboxy-5,8,11-tris(carboxymethyl)-1-phenyl-2-oxa-5,8,11-triazatridecan-13-carbonsäure
ATE118470T1 (de)	1995-03-15	Isolierung von l-phenylalanin aus dessen racemischen mischungen.
DE60011739D1 (de)	2004-07-29	Kristallines oder kristallisiertes Säureadditionssalz von Losartan und Verfahren zur Reinigung von Losartan
DE50100315D1 (de)	2003-07-24	Verfahren zur Herstellung von 2,3,5-Trimethyl-p-benzochinon

Legal Events

Date	Code	Title	Description
2010-07-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties